| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.5M | +177.9% |
| SG&A Expense | $29.3M | +109.9% |
| Operating Income | $2.2M | -64.0% |
| Pre-tax Income | $12.0M | +258.5% |
| Income Tax | $2K | -98.3% |
| Net Income | $11.7M | +267.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.4M | +234.5% |
| Total Assets | $72.0M | +67.4% |
| Total Liabilities | $1.9M | -66.4% |
| Stockholders' Equity | $70.2M | +88.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | -26.2% |
| Investing Cash Flow | $22.9M | +379.2% |
| Financing Cash Flow | $69K | -99.6% |